Sharifi Emile, Sharifi Husham, Morshed Saam, Bozic Kevin, Diab Mohammad
School of Medicine, University of California at San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.
J Bone Joint Surg Am. 2008 Jul;90(7):1447-56. doi: 10.2106/JBJS.G.00730.
A lack of long-term outcomes data following periacetabular osteotomy makes it difficult for surgeons to recommend the most appropriate procedure to young patients who might be candidates for a joint-preserving procedure. In this study, we compared the cost-effectiveness of periacetabular osteotomy with total hip arthroplasty in terms of cost per quality-adjusted life year for the young adult.
A decision model was constructed for a cost-utility analysis of periacetabular osteotomy compared with total hip arthroplasty. Outcome probabilities and effectiveness were derived from the literature. Effectiveness was expressed in quality-adjusted life years gained. Cost data were compiled and verified from our institution. Costs and utilities were discounted in accord with the United States Panel on Cost-Effectiveness in Health and Medicine. Principal outcome measures were average incremental costs, incremental effectiveness, incremental quality-adjusted life years, and net health benefits. Multivariate sensitivity analysis was used to assess the contribution of included variables in the model's outcomes.
For Tönnis grade-1 coxarthrosis, periacetabular osteotomy dominates with an average incremental cost-effectiveness of $7856 per quality-adjusted life year and an average incremental effectiveness of 0.15. For Tönnis grade-2 coxarthrosis, periacetabular osteotomy is, on the average, more cost-effective than total hip arthroplasty with an incremental cost-effectiveness of $824 per quality-adjusted life year, but it is less effective than total hip arthroplasty, on the average, with an incremental effectiveness of -1.4 quality-adjusted life years. Periacetabular osteotomy becomes more cost-effective at a longevity of 5.5 years for Tönnis grade-1 coxarthrosis and 18.25 years for Tönnis grade-2 coxarthrosis. In Tönnis grade-3 coxarthrosis, total hip replacement becomes the dominant treatment strategy.
Periacetabular osteotomy is, on the average, more cost-effective in Tönnis grade-1 and grade-2 coxarthrosis, while it is both more costly and less effective in Tönnis grade-3 coxarthrosis. These findings can inform clinical decision-making in the absence of long-term data. On the basis of this model, periacetabular osteotomy is preferable to total hip arthroplasty in Tönnis grade-1 and grade-2 coxarthrosis when the patient is sufficiently young and when functionality in sports is important.
髋臼周围截骨术后缺乏长期疗效数据,这使得外科医生难以向可能适合保关节手术的年轻患者推荐最合适的手术方式。在本研究中,我们从每质量调整生命年成本的角度,比较了髋臼周围截骨术与全髋关节置换术对年轻成年人的成本效益。
构建了一个决策模型,用于对髋臼周围截骨术与全髋关节置换术进行成本效用分析。结果概率和有效性数据来自文献。有效性以获得的质量调整生命年表示。成本数据从我们的机构收集并核实。成本和效用按照美国卫生与医学成本效益小组的标准进行贴现。主要结局指标为平均增量成本、增量有效性、增量质量调整生命年和净健康效益。采用多变量敏感性分析来评估模型中纳入变量对结局的贡献。
对于Tönnis 1级髋关节病,髋臼周围截骨术占优势,平均增量成本效益为每质量调整生命年7856美元,平均增量有效性为0.15。对于Tönnis 2级髋关节病,髋臼周围截骨术平均比全髋关节置换术更具成本效益,增量成本效益为每质量调整生命年824美元,但平均有效性低于全髋关节置换术,增量有效性为-1.4个质量调整生命年。对于Tönnis 1级髋关节病,髋臼周围截骨术在5.5年的寿命时变得更具成本效益;对于Tönnis 2级髋关节病,在18.25年的寿命时更具成本效益。在Tönnis 3级髋关节病中,全髋关节置换术成为主要的治疗策略。
平均而言,髋臼周围截骨术在Tönnis 1级和2级髋关节病中更具成本效益,而在Tönnis 3级髋关节病中成本更高且效果更差。这些发现可为缺乏长期数据时的临床决策提供参考。基于该模型,当患者足够年轻且运动功能很重要时,在Tönnis 1级和2级髋关节病中,髋臼周围截骨术优于全髋关节置换术。